Thermo Fisher Scientific Inc.

NYSE-TMO

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						25,542	32,218	39,211	44,915	42,857	42,346
Total Revenues % Chg.						4.9%	26.1%	21.7%	14.5%	-4.6%	-2.7%
Cost of Goods Sold, Total						14,214	16,214	19,573	25,944	25,744	25,114
Gross Profit						11,328	16,004	19,638	18,971	17,113	17,232
Selling General & Admin Expenses, Total						6,139	6,940	7,857	8,940	8,381	8,469
R&D Expenses						1,003	1,181	1,406	1,471	1,337	1,316
Other Operating Expenses				—	—	—	16	3	—	1	1
Other Operating Expenses, Total						7,142	8,137	9,266	10,411	9,719	9,786
Operating Income						4,186	7,867	10,372	8,560	7,394	7,446
Interest Expense, Total						-676	-553	-536	-726	-1,375	-1,461
Interest And Investment Income						224	65	43	272	879	1,129
Net Interest Expenses						-452	-488	-493	-454	-496	-332
Income (Loss) On Equity Invest.	—	—	—	—	—	—	-3	-4	-172	-59	-79
Currency Exchange Gains (Loss)	—	—	—	—	—	—	—	162	102	-29	-37
Other Non Operating Income (Expenses)						65	5	-161	-35	5	13
EBT, Excl. Unusual Items						3,799	7,381	9,876	8,001	6,815	7,011
Restructuring Charges						-52	-51	-37	-68	-233	-44
Merger & Related Restructuring Charges						—	-81	-35	—	—	33
Gain (Loss) On Sale Of Investments		—				44	10	66	-161	-46	8
Gain (Loss) On Sale Of Assets				—		482	—	—	14	—	—
Asset Writedown	—		—	—	—	—	-32	-122	-60	-219	-219
Legal Settlements						—	—	—	—	-19	-19
Other Unusual Items						-201	—	-911	-63	-59	9
EBT, Incl. Unusual Items						4,072	7,227	8,837	7,663	6,239	6,779
Income Tax Expense						374	850	1,109	703	284	594
Earnings From Continuing Operations						3,698	6,377	7,728	6,960	5,955	6,185
Earnings Of Discontinued Operations					—	—	—	—	—	—	—
Minority Interest	—	—	—	—	—	-2	-2	-3	-10	40	35
Net Income						3,696	6,375	7,725	6,950	5,995	6,220
Net Income to Common Incl Extra Items						3,696	6,375	7,725	6,950	5,995	6,220
Net Income to Common Excl. Extra Items						3,696	6,375	7,725	6,950	5,995	6,220
Total Shares Outstanding						398.7	396.7	394.4	390.5	386.6	382
Weighted Avg. Shares Outstanding						400	396	394	392	386	384
Weighted Avg. Shares Outstanding Dil						403	399	397	394	388	385.5
EPS						9.2	16.1	19.6	17.7	15.5	16.2
EPS Diluted						9.2	16	19.5	17.6	15.5	16.1
EBITDA						6,463	10,192	12,964	11,941	10,800	10,765
Effective Tax Rate						9.2%	11.8%	12.5%	9.2%	4.6%	8.8%